Şunu aradınız:: toxoid (İtalyanca - Fince)

- diphtheria toxoid, -
- diphtheria toxoid, -

tetanus toxoid ≥ 40iu
tetanus toxoid ≥ 40iu

purified tetanus toxoid,
purified tetanus toxoid, adsorbed ≥ 40 iu

tetanus toxoid, adsorbed ≥
40iu

- diphtheria toxoid, - 201 days -
- diphtheria toxoid, - 201 days -

suspension for injection diphtheria toxoid ≥ 30iu
suspension for injection diphtheria toxoid ≥ 30iu

g17(9) gastrin-diphtheria toxoid conjugate
g17( 9) gastrin- diphtheria toxoid conjugate

suspension for injection diphtheria toxoid, adsorbed ≥ 30iu
suspension for injection diphtheria toxoid, adsorbed ≥ 30iu

pertussis toxoid 5µg fha 2.5µg pertactin 2.5µg 9 presentations
pertussis toxoid 5µg fha 2. 5µg pertactin 2. 5µg 9 presentations

suspension for injection purified diphtheria toxoid, adsorbed ≥ 20 iu,
suspension for injection purified diphtheria toxoid, adsorbed ≥ 20 iu,

* hib prp - haemophilus influenzae type b polyribosylribitol phosphate tt - tetanus toxoid menc psc - neisseria meningitidis serogroup c polysaccharide
* hib prp - haemophilus influenzae tyyppi b polyribosyyliribitolifosfaatti tt - tetanus toksoidi menc psc - neisseria meningitidis seroryhmä c polysakkaridi

pertussis toxoid, adsorbed 25 µg filamentous haemagglutinin, adsorbed 25 µg pertactin, adsorbed 8 µg recombinant hepatitis b surface antigen (s protein), adsorbed 10 µg inactivated type 1 poliovirus 40 du inactivated type 2 poliovirus 8 du inactivated type 3 poliovirus 32 du conjugate of haemophilus influenzae type b capsular polysaccharide (prp) 10 µg and tetanus toxoid (t), adsorbed (prp-t) 20-40 µg
pertussis toxoid, adsorbed 25 µg filamentous haemagglutinin, adsorbed 25 µg pertactin, adsorbed 8 µ g recombinant hepatitis b surface antigen (s protein), adsorbed 10 µg inactivated type 1 poliovirus 40 du inactivated type 2 poliovirus 8 du inactivated type 3 poliovirus 32 du conjugate of haemophilus influenzae type b capsular polysaccharide (prp) 10 µg and tetanus toxoid (t), adsorbed (prp- t) 20- 40 µg